[1]
S. Schlootz, F. A. M. Saner, M. Rabaglio, S. Imboden, and J. Wampfler, “Feasibility and cost-effectiveness of genetic counselling for all patients with newly diagnosed ovarian cancer: a single-centre retrospective study”, Swiss Med Wkly, vol. 154, no. 4, p. 3386, Apr. 2024.